456 Results
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Symptom Management
Symptom Management
Symptom Management
Drug
Other Name(s): Neulasta®
, Lapelga™
, Fulphila™
, Ziextenzo®
, Nyvepria™
Dec 2022
Drug
Apr 2023
Drug
Feb 2024
Drug
Dec 2019
Drug
Sep 2022
Drug
Aug 2023